Skip to main content
All lobbying filings

FORBES-TATE

Lobbying for INDEPENDENT PHARMACY COOPERATIVE · Largest group purchasing organization for independent pharmacies.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Wisconsin · House · Senate · $40,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 5
  • S 891
    Bipartisan Health Care Act
  • S 927
    Protecting Pharmacies in Medicaid Act
  • HR 4317
    PBM Reform Act of 2025
  • S 2426
    Equitable Community Access to Pharmacist Services Act
  • S 3822
    Break Up Big Medicine Act
 Lobbying activity 5
Health Issues

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.

Pharmacy

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.

Medicare/Medicaid

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation program; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 927 - Protecting Pharmacies in Medicaid Act; Issues related to H.R. 4317 - PBM Reform Act of 2025; Issues related to S. 2426 - Equitable Community Access to Pharmacist Services Act.

Budget/Appropriations

Issues related to Pharmacy Benefit Manager (PBM) transparency and reform and continued implementation of the Medicare Drug Price Negotiation Program in the One Big Beautiful Bill Act (P.L. 119-21).

Consumer Issues/Safety/Products

Issues related to S.3822 - Break Up Big Medicine Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem